Our Bureau

Hyderabad, Dec 15

AUROBINDO Pharma Ltd has announced that three of its US patents have been selected for the `Patent Appreciation Award' of the Indian Drug Manufacturers' Association (IDMA) for 2004-05.

In a release on Thursday, the company said that it was selected for the award based on patents for pure Citalopram (depression), a process for lactonisation to produce Simvastatin (hypercholesterolemia), and process for producing highly pure Simvastatin (hypercholesterolemia).

The company will receive the IDMA national level award at a function to be held at Mumbai on December 17 on the eve of IDMA's 44th annual day celebrations.

(This article was published in the Business Line print edition dated December 16, 2005)
XThese are links to The Hindu Business Line suggested by Outbrain, which may or may not be relevant to the other content on this page. You can read Outbrain's privacy and cookie policy here.